CompletedNot Applicable

Barriers to Optimal LDL-C Targets in Patients With Atherosclerotic Cardiovascular Disease

Egypt1,000 participantsStarted 2024-09-21

Plain-language summary

In the present cross-sectional observational study, the investigators aimed to: * Evaluate the prevalence of achievement of LDL-C targets among a sample of Egyptian ASCVD patients. * Attempt to unveil the potential barriers to achieve LDL-C goals in order to determine the appropriate corrective actions.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients presenting to cardiology department/ outpatient clinic. * Established ASCVD and eligible for high intensity statins for at least six-months. * Age between18-to-80y. Exclusion Criteria: * Refusal to participate in the survey. * Recent diagnosis of ASCVD with indication to high intensity statins for a period \< six-months. * Patients with medical limitation or contraindications to statins therapy. * Patients with documented diagnosis of homozygous familial hypercholesterolemia.

What they're measuring

Prevalence of achievement of recommended LDL-C targets among patients with established ASCVD

Timeframe: Being a cross sectional study selectively recruiting patients with established indication for >6months, the study will accept a fasting lipid profile that was performed within 1 month from surveying the recruited patient.

Trial details

NCT IDNCT06897566

SponsorCairo University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-11-01

View on ClinicalTrials.gov More Coronary Artery Disease trials